AustinPx Partners with Microsize on KinetiSol® Technology

AustinPx Partners with Microsize on KinetiSol® Technology

Business Wire

Published

GEORGETOWN, Texas--(BUSINESS WIRE)--AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates, and Microsize, a leading active pharmaceutical ingredient enhancement CDMO, today announced the strategic partnership to accelerate the commercial application of AustinPx’s KinetiSol® Technology platform. The collaboration will enable AustinPx’s clients to manufacture their late-phase clinical a

Full Article